Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).

被引：1
|
作者：
Kim, Se Eun
Cole, Suzanne
Wulff-Burchfield, Elizabeth Marie
Wentland, Andrew
Hannan, Mu-Han
Kapur, Payal
Shevrin, Daniel
Gurley, Tami
Lin, John Kent
Brugarolas, James
Timmerman, Robert D.
Mckay, Rana R.
Wagner, Lynne I.
Haas, Naomi B.
Carducci, Michael Anthony
机构：
[1] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[2] DFCI PCC Fellowship Program Attendings, Boston, MA USA
[3] Univ Kansas, Med Ctr, Westwood, KS USA
[4] Univ Wisconsin, Madison, WI USA
[5] Univ Texas Southwestern, Dept Pathol, Dallas, TX USA
[6] Northshore Univ Hlth Syst, Evanston, IL USA
[7] UT Southwestern Med Ctr, Dallas, TX USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[9] Univ Texas Southwestern, Div Hematol & Oncol, Dept Internal Med, Dallas, TX USA
[10] Univ Texas Southwestern Med Ctr, Radiat Oncol, Dallas, TX USA
[11] Univ Calif San Diego, La Jolla, CA USA
[12] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[13] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-11347; 261-137-3222-3876-5567; 283-424-3231; 261-492-3532-2370-7650-2700; 3282-270-434-2806; 261-492-199; 261-137; 11; 10; 6; 5; 4;
D O I：
10.1200/JCO.2024.42.4_suppl.TPS489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：TPS489 / TPS489
页数：1
相关论文
共 50 条
  • [41] A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
    Tran, Phuoc T.
    Phillips, Ryan
    Shi, William
    Lim, Su Jin
    Antonarakis, Emmanuel S.
    Rowe, Steven P.
    Ross, Ashley
    Gorin, Michael A.
    Deville, Curtiland
    Greco, Stephen C.
    Paller, Channing Judith
    DeWeese, Theodore L.
    Song, Daniel Y.
    Wang, Hao
    Carducci, Michael Anthony
    Pienta, Kenneth J.
    Pomper, Martin
    Dicker, Adam P.
    Eisenberger, Mario A.
    Diehn, Maximilian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [42] A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE).
    Phillips, Ryan
    Radwan, Noura
    Ross, Ashley
    Rowe, Steven P.
    Gorin, Michael A.
    Antonarakis, Emmanuel S.
    Deville, Curtiland
    Greco, Stephen C.
    Denmeade, Samuel R.
    Paller, Channing Judith
    Song, Daniel Y.
    Diehn, Maximilian
    Wang, Hao
    Carducci, Michael Anthony
    Pienta, Kenneth J.
    Pomper, Martin G.
    DeWeese, Theodore L.
    Dicker, Adam P.
    Eisenberger, Mario A.
    Tran, Phuoc T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
    Radwan, Noura
    Phillips, Ryan
    Ross, Ashley
    Rowe, Steven P.
    Gorin, Michael A.
    Antonarakis, Emmanuel S.
    Deville, Curtiland
    Greco, Stephen
    Denmeade, Samuel
    Paller, Channing
    Song, Daniel Y.
    Diehn, Maximilian
    Wang, Hao
    Carducci, Michael
    Pienta, Kenneth J.
    Pomper, Martin G.
    DeWeese, Theodore L.
    Dicker, Adam
    Eisenberger, Mario
    Tran, Phuoc T.
    BMC CANCER, 2017, 17
  • [44] Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
    Palma, David A.
    Olson, Robert
    Harrow, Stephen
    Gaede, Stewart
    Louie, Alexander V.
    Haasbeek, Cornelis
    Mulroy, Liam
    Lock, Michael
    Rodrigues, George B.
    Yaremko, Brian P.
    Schellenberg, Devin
    Ahmad, Belal
    Griffioen, Gwendolyn
    Senthi, Sashendra
    Swaminath, Anand
    Kopek, Neil
    Liu, Mitchell
    Moore, Karen
    Currie, Suzanne
    Bauman, Glenn S.
    Warner, Andrew
    Senan, Suresh
    LANCET, 2019, 393 (10185): : 2051 - 2058
  • [45] A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
    Noura Radwan
    Ryan Phillips
    Ashley Ross
    Steven P. Rowe
    Michael A. Gorin
    Emmanuel S. Antonarakis
    Curtiland Deville
    Stephen Greco
    Samuel Denmeade
    Channing Paller
    Daniel Y. Song
    Maximilian Diehn
    Hao Wang
    Michael Carducci
    Kenneth J. Pienta
    Martin G. Pomper
    Theodore L. DeWeese
    Adam Dicker
    Mario Eisenberger
    Phuoc T. Tran
    BMC Cancer, 17
  • [46] A Phase II Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cell Cancer
    McLaughlin, M.
    Kapur, P.
    Pedrosa, I.
    Ahn, C.
    Robles, L.
    Garant, A.
    Brugarolas, J.
    Woldu, S.
    Bagrodia, A.
    Choy, H.
    Gahan, J.
    Margulis, V.
    Timmerman, R. D.
    Cadeddu, J.
    Hannan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E865 - E866
  • [47] Re: Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer
    Bourillon, Alice
    Bensalah, Karim
    EUROPEAN UROLOGY, 2024, 86 (01) : 76 - 76
  • [48] Prostate cancer with oligometastatic relapse: Combining stereotactic ablative radiotherapy and durvalumab, a randomized phase II trial (POSTCARD - GETUG-P13).
    Supiot, Stephane
    Libois, Vincent
    Guimas, Valentine
    Rio, Emmanuel
    Rolland, Frederic
    Bompas, Emmanuelle
    Vansteene, Damien
    Tigreat, Marine
    Lisbona, Albert
    Colliaux, Jeremy
    Campion, Loic
    Blanc-Lapierre, Audrey
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Immune Correlates of Abscopal Response in a Lead-in Phase II Trial of Neoadjuvant Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus
    Pop, L. M.
    Manna, S.
    Christley, S.
    Freifeld, Y.
    Vo, D. T.
    Filatenkov, A.
    Kapur, P.
    Monson, N.
    Pedrosa, I.
    Brugarolas, J.
    Timmerman, R. D.
    Margulis, V.
    Cowell, L. G.
    Hannan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S26 - S26
  • [50] A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC).
    Keane, Fergus
    Schoenfeld, Joshua David
    Crowley, Fionnuala
    O'Connor, Catherine Anne
    White, Charlie
    Schwartz, Carly
    Brenner, Robin
    Larsen, Mary
    Park, Wungki
    Varghese, Anna M.
    Yu, Kenneth H.
    Li, Jia
    Zervoudakis, Alice
    Goldberg, Zoe
    Chou, Joanne F.
    Vardhana, Santosha
    Reyngold, Marsha
    Crane, Christopher H.
    Tuli, Richard
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 725 - 725
12345